Metabolic syndrome and its components predict the development of arterial stiffening in a sample of adult men. (2nd January 2022)
- Record Type:
- Journal Article
- Title:
- Metabolic syndrome and its components predict the development of arterial stiffening in a sample of adult men. (2nd January 2022)
- Main Title:
- Metabolic syndrome and its components predict the development of arterial stiffening in a sample of adult men
- Authors:
- D'Elia, Lanfranco
Barbato, Antonio
Iacone, Roberto
Russo, Ornella
Strazzullo, Pasquale
Galletti, Ferruccio - Abstract:
- ABSTRACT: Background and Objective: Metabolic syndrome (MS) and its components are associated with greater cardiovascular risk. A number of studies found a positive association between MS and vascular damage, but few observational studies evaluated the predictive role of MS on arterial stiffening (AS). Therefore, the aim of this study was to estimate the ability of MS and its components to predict the risk of AS in an 8-year follow-up of a sample of adult men (Olivetti Heart Study). Methods: The analysis included 778 men without AS (pulse pressure >60 mmHg) at baseline. A positive diagnosis of MS was made by recognized criteria, if at least three components were present. Results: At the end of the follow-up period, there was an incidence of 11% in AS. The percentage of participants that developed AS was greater in the MS group than those without MS, also after adjustment for main confounders (odds ratio: 2.5, 95% confidence interval: 1.3–4.9). The risk of AS also increased with increase in the numbers of MS elements ( p for trend <.01). In addition, the analysis of the predictive role of the single MS component showed that high blood pressure (HBP) was the strongest predictor. Conclusions: The results of this prospective study indicate a predictive role of MS on AS, independently of main confounders. In addition, HBP seems the strongest predictor of AS among MS components.
- Is Part Of:
- Clinical and experimental hypertension. Volume 44:Number 1(2022)
- Journal:
- Clinical and experimental hypertension
- Issue:
- Volume 44:Number 1(2022)
- Issue Display:
- Volume 44, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 44
- Issue:
- 1
- Issue Sort Value:
- 2022-0044-0001-0000
- Page Start:
- 26
- Page End:
- 33
- Publication Date:
- 2022-01-02
- Subjects:
- Arterial stiffening -- pulse pressure -- metabolic syndrome -- blood pressure
Hypertension -- Chemotherapy -- Periodicals
Hypotensive agents -- Periodicals
616.132 - Journal URLs:
- http://informahealthcare.com/loi/ceh ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/10641963.2021.1969664 ↗
- Languages:
- English
- ISSNs:
- 1064-1963
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.250500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20318.xml